Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This is a phase IV prospective trial to collect and analyze information about the maternal
pharmacokinetics of amlodipine besylate at the time of delivery and during postpartum
lactation. The study will also evaluate amlodipine concentrations in the infants of
breastfeeding mothers who are taking amlodipine besylate for treatment chronic hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
National Center for Advancing Translational Science (NCATS)